Lake Street Maintains P3 Health Partners(PIII.US) With Buy Rating, Maintains Target Price $4.5
Lake Street Maintains P3 Health Partners(PIII.US) With Buy Rating, Maintains Target Price $4.5
Lake Street Reaffirms Their Buy Rating on P3 Health Partners (PIII)
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and P3 Health Partners (PIII)
P3 Health Partners (PIII) Gets a Buy From Lake Street
P3 Health Partners Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
P3 Health Partners Analyst Ratings
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4.5
Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and P3 Health Partners (PIII)
P3 Health Partners (PIII) Gets a Buy From BTIG
Positive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen's Buy Rating for P3 Health Partners
BTIG Keeps Their Buy Rating on P3 Health Partners (PIII)
BTIG Initiates Coverage On P3 Health Partners With Buy Rating, Announces Price Target of $5
P3 Health Partners Analyst Ratings
P3 Health Partners (PIII) Initiated With a Buy at BTIG
No Data
No Data